Targeting p38α Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells

被引:76
作者
Canovas, Begona [1 ]
Igea, Ana [1 ]
Sartori, Alessandro A. [2 ]
Gomis, Roger R. [1 ,3 ,4 ,5 ]
Paull, Tanya T. [6 ]
Isoda, Michitaka [1 ]
Perez-Montoyo, Hector [7 ]
Serra, Violeta [8 ]
Gonzalez-Suarez, Eva [7 ]
Stracker, Travis H. [1 ]
Nebreda, Angel R. [1 ,3 ]
机构
[1] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain
[2] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland
[3] ICREA, Pg Lluis Co 23, Barcelona 08010, Spain
[4] Univ Barcelona, Barcelona, Spain
[5] CIBERONC, Barcelona, Spain
[6] Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA
[7] Bellvitge Biomed Res Inst IDIBELL, PEBC, Barcelona 08908, Spain
[8] VHIO, Barcelona 08035, Spain
基金
欧洲研究理事会;
关键词
END RESECTION; HOMOLOGOUS RECOMBINATION; REPLICATION STRESS; CHECKPOINT KINASE; MAMMALIAN-CELLS; GENOMIC INSTABILITY; MIS-SEGREGATION; P38; MAPK; REPAIR; CTIP;
D O I
10.1016/j.ccell.2018.04.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is the second leading cause of cancer-related death among women. Here we report a role for the protein kinase p38 alpha in coordinating the DNA damage response and limiting chromosome instability during breast tumor progression, and identify the DNA repair regulator CtIP as a p38 alpha substrate. Accordingly, decreased p38 alpha signaling results in impaired ATR activation and homologous recombination repair, with concomitant increases in replication stress, DNA damage, and chromosome instability, leading to cancer cell death and tumor regression. Moreover, we show that pharmacological inhibition of p38 alpha potentiates the effects of taxanes by boosting chromosome instability in murine models and patient-derived xenografts, suggesting the potential interest of combining p38 alpha inhibitors with chemotherapeutic drugs that induce chromosome instability.
引用
收藏
页码:1094 / +
页数:25
相关论文
共 53 条
[1]   Phosphorylated CtIP Functions as a Co-factor of the MRE11-RAD50-NBS1 Endonuclease in DNA End Resection [J].
Anand, Roopesh ;
Ranjha, Lepakshi ;
Cannavo, Elda ;
Cejka, Petr .
MOLECULAR CELL, 2016, 64 (05) :940-950
[2]   Polo-like kinase 3 regulates CtIP during DNA double-strand break repair in G1 [J].
Barton, Olivia ;
Naumann, Steffen C. ;
Diemer-Biehs, Ronja ;
Kuenzel, Julia ;
Steinlage, Monika ;
Conrad, Sandro ;
Makharashvili, Nodar ;
Wang, Jiadong ;
Feng, Lin ;
Lopez, Bernard S. ;
Paull, Tanya T. ;
Chen, Junjie ;
Jeggo, Penny A. ;
Loebrich, Markus .
JOURNAL OF CELL BIOLOGY, 2014, 206 (07) :877-894
[3]   Paradoxical Relationship between Chromosomal Instability and Survival Outcome in Cancer [J].
Birkbak, Nicolai J. ;
Eklund, Aron C. ;
Li, Qiyuan ;
McClelland, Sarah E. ;
Endesfelder, David ;
Tan, Patrick ;
Tan, Iain B. ;
Richardson, Andrea L. ;
Szallasi, Zoltan ;
Swanton, Charles .
CANCER RESEARCH, 2011, 71 (10) :3447-3452
[4]   Replication stress links structural and numerical cancer chromosomal instability [J].
Burrell, Rebecca A. ;
McClelland, Sarah E. ;
Endesfelder, David ;
Groth, Petra ;
Weller, Marie-Christine ;
Shaikh, Nadeem ;
Domingo, Enric ;
Kanu, Nnennaya ;
Dewhurst, Sally M. ;
Gronroos, Eva ;
Chew, Su Kit ;
Rowan, Andrew J. ;
Schenk, Arne ;
Sheffer, Michal ;
Howell, Michael ;
Kschischo, Maik ;
Behrens, Axel ;
Helleday, Thomas ;
Bartek, Jiri ;
Tomlinson, Ian R. ;
Swanton, Charles .
NATURE, 2013, 494 (7438) :492-496
[5]   Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity [J].
Campbell, Robert M. ;
Anderson, Bryan D. ;
Brooks, Nathan A. ;
Brooks, Harold B. ;
Chan, Edward M. ;
De Dios, Alfonso ;
Gilmour, Raymond ;
Graff, Jeremy R. ;
Jambrina, Enrique ;
Mader, Mary ;
McCann, Denis ;
Na, Songqing ;
Parsons, Stephen H. ;
Pratt, Susan E. ;
Shih, Chuan ;
Stancato, Louis F. ;
Starling, James J. ;
Tate, Courtney ;
Velasco, Juan A. ;
Wang, Yong ;
Ye, Xiang S. .
MOLECULAR CANCER THERAPEUTICS, 2014, 13 (02) :364-374
[6]   A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers [J].
Carter, Scott L. ;
Eklund, Aron C. ;
Kohane, Isaac S. ;
Harris, Lyndsay N. ;
Szallasi, Zoltan .
NATURE GENETICS, 2006, 38 (09) :1043-1048
[7]   Inhibition of the p38 Kinase Suppresses the Proliferation of Human ER-Negative Breast Cancer Cells [J].
Chen, Lu ;
Mayer, Julie Ann ;
Krisko, Tibor I. ;
Speers, Corey W. ;
Wang, Tao ;
Hilsenbeck, Susan G. ;
Brown, Powel H. .
CANCER RESEARCH, 2009, 69 (23) :8853-8861
[8]   Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors [J].
Daud, Adil I. ;
Ashworth, Michelle T. ;
Strosberg, Jonathan ;
Goldman, Jonathan W. ;
Mendelson, David ;
Springett, Gregory ;
Venook, Alan P. ;
Loechner, Sabine ;
Rosen, Lee S. ;
Shanahan, Frances ;
Parry, David ;
Shumway, Stuart ;
Grabowsky, Jennifer A. ;
Freshwater, Tomoko ;
Sorge, Christopher ;
Kang, Soonmo Peter ;
Isaacs, Randi ;
Munster, Pamela N. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (09) :1060-+
[9]   A Synergistic Interaction between Chk1-and MK2 Inhibitors in KRAS-Mutant Cancer [J].
Dietlein, Felix ;
Kalb, Bastian ;
Jokic, Mladen ;
Noll, Elisa M. ;
Strong, Alexander ;
Tharun, Lars ;
Ozretic, Luka ;
Kuenstlinger, Helen ;
Kambartel, Kato ;
Randerath, Winfried J. ;
Juengst, Christian ;
Schmitt, Anna ;
Torgovnick, Alessandro ;
Richters, Andre ;
Rauh, Daniel ;
Siedek, Florian ;
Persigehl, Thorsten ;
Mauch, Cornelia ;
Bartkova, Jirina ;
Bradley, Allan ;
Sprick, Martin R. ;
Trumpp, Andreas ;
Rad, Roland ;
Saur, Dieter ;
Bartek, Jiri ;
Wolf, Juergen ;
Buettner, Reinhard ;
Thomas, Roman K. ;
Reinhardt, H. Christian .
CELL, 2015, 162 (01) :146-159
[10]   Exploiting replicative stress to treat cancer [J].
Dobbelstein, Matthias ;
Sorensen, Claus Storgaard .
NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (06) :405-423